Induced sputum concentrations of mucin in patients with asthma and chronic cough

Chest

Volumn 137, Issue 5, 2010, Pages 1122-1129

  Jinnai, Makiko ^a   Niimi, Akio ^a   Ueda, Tetsuya ^b   Matsuoka, Hirofumi ^a   Takemura, Masaya ^c   Yamaguchi, Masafumi ^a   Otsuka, Kojiro ^a   Oguma, Tsuyoshi ^a   Takeda, Tomoshi ^a   Ito, Isao ^a   Matsumoto, Hisako ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SAISEIKAI NAKATSU HOSPITAL   (Japan)

^c Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; IMMUNOGLOBULIN E; METHACHOLINE; MUCIN; MUCIN 5AC; MUCIN 5B;

ADULT; AGED; AIRWAY; ARTICLE; ASTHMA; BRONCHUS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FUNCTION TEST; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MUCUS SECRETION; OSCILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; SINOBRONCHIAL SYNDROME; SPIROMETRY; SPUTUM LEVEL; SUPERNATANT;

EID: 77951775935     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0081     Document Type: Article

References (49)

1. Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J. 1999;13(4):904-918. (Pubitemid 29234799)
2. Kuyper LM, Paré PD, Hogg JC, et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115(1):6-11.
3. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest. 2006;129(4):1068-1087.
4. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134-155. (Pubitemid 47074016)
5. Shimura S, Sasaki T, Sasaki H, Takishima T, Umeya K. Viscoelastic properties of bronchorrhoea sputum in bronchial asthmatics. Biorheology. 1988;25(1-2):173-179.
6. Messina MS, O'Riordan TG, Smaldone GC. Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis. 1991;143(5 pt 1):993-997.
7. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J. 1996;9(7):1395-1401. (Pubitemid 26233780)
8. Ordoñez CL, Khashayar R, Wong HH, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 2001;163(2):517-523. (Pubitemid 32158539)
9. Irwin RS, Madison JM. The persistently troublesome cough. Am J Respir Crit Care Med. 2002;165(11):1469-1474.
10. Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest. 1995;108(4):991-997.
11. Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol. 2005;116(3):565-570. (Pubitemid 41267129)
12. Kohno S, Ishida T, Uchida Y, et al; Committee for the Japanese Respiratory Society Guidelines for Management of Cough. The Japanese Respiratory Society guidelines for management of cough. Respirology. 2006;11( suppl 4 ):S135-S186.
13. Niimi A. Geography and cough aetiology. Pulm Pharmacol Ther. 2007;20(4):383-387.
14. Matsumoto H, Niimi A, Tabuena RP, et al. Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest. 2007;131(4):1042-1049. (Pubitemid 46608705)
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987;136(1):225-244.
16. National Institute of Health/National Heart, Lung, and Blood Institute. Global Strategy for Asthma Management and Prevention. Publication 02-3659. Bethesda, MD: National Institute of Health/National Heart, Lung, and Blood Institute; 2004.
17. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633-637. (Pubitemid 9140174)
18. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25-29.
19. Takemura M, Niimi A, Minakuchi M, et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest. 2004;125(4):1352-1358. (Pubitemid 38501349)
20. Doherty MJ, Mister R, Pearson MG, Calverley PM. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax. 2000;55(8):643-649. (Pubitemid 30468218)
21. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application. Chest. 1981;80(5):600-606.
22. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003;168(8):983-988. (Pubitemid 37267177)
23. Oostveen E, MacLeod D, Lorino H, et al; ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026-1041.
24. Marotta A, Klinnert MD, Price MR, Larsen GL, Liu AH. Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol. 2003;112(2):317-322. (Pubitemid 36981371)
25. Skloot G, Goldman M, Fischler D, et al. Respiratory symptoms and physiologic assessment of ironworkers at the World Trade Center disaster site. Chest. 2004;125(4):1248-1255. (Pubitemid 38501335)
26. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
27. Yamaguchi M, Niimi A, Ueda T, et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther. 2009;22(4):326-332.
28. Claman DM, Boushey HA, Liu J, Wong H, Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol. 1994;94(5):861-869. (Pubitemid 24354484)
29. Matsuoka H, Niimi A, Matsumoto H, et al. Patients' characteristics associated with unsuccessful sputum induction in asthma. J Allergy Clin Immunol. 2008;121(3):774-776.
30. Lin H, Carlson DM, St George JA, Plopper CG, Wu R. An ELISA method for the quantitation of tracheal mucins from human and nonhuman primates. Am J Respir Cell Mol Biol. 1989;1(1):41-48.
31. Efthimiadis A, Pizzichini MMM, Pizzichini E, Dolovich J, Hargreave FE. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. Eur Respir J. 1997;10(6):1336-1340. (Pubitemid 27278256)
32. Takeyama K, Jung B, Shim JJ, et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2001;280(1):L165-L172. (Pubitemid 32473248)
33. Pizzichini MM, Popov TA, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996;154(4 pt 1):866-869. (Pubitemid 126679515)
34. Dauletbaev N, Rickmann J, Viel K, Buhl R, Wagner TO, Bargon J. Glutathione in induced sputum of healthy individuals and patients with asthma. Thorax. 2001;56(1):13-18. (Pubitemid 32041713)
35. Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002;37:19s-23s. (Pubitemid 35024263)
36. Xiang A, Uchida Y, Nomura A, et al. Involvement of thromboxane A(2) in airway mucous cells in asthma-related cough. J Appl Physiol. 2002;92(2):763-770.
37. Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002;57(8):677-682. (Pubitemid 34864522)
38. James AL, Elliot JG, Abramson MJ, Walters EH. Time to death, airway wall inflammation and remodelling in fatal asthma. Eur Respir J. 2005;26(3):429-434.
39. Connolly CK, Murthy NK, Alcock SM, Prescott RJ. Sputum and pulmonary function in asthma. Chest. 1997;112(4):994-999.
40. King M, Kelly S, Cosio M. Alteration of airway reactivity by mucus. Respir Physiol. 1985;62(1):47-59.
41. Kim CS, Eldridge MA, Wanner A. Airway responsiveness to inhaled and intravenous carbachol in sheep: effect of airway mucus. J Appl Physiol. 1988;65(6):2744-2751. (Pubitemid 19026447)
42. Kasper M, Sims G, Koslowski R, et al. Increased surfactant protein D in rat airway goblet and Clara cells during ovalbumin-induced allergic airway inflammation. Clin Exp Allergy. 2002;32(8):1251-1258. (Pubitemid 35007432)
43. Kim CS, Eldridge MA. Aerosol deposition in the airway model with excessive mucus secretions. J Appl Physiol. 1985;59(6):1766-1772.
44. Rogers DF. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? Clin Exp Allergy. 2002;32(8):1124-1127.
45. Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol. 2001;167(10):5948-5954.
46. Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Mucus hypersecretion and eosinophils in bronchoalveolar lavage fluid in adult patients with bronchial asthma. J Asthma. 1993;30(4):257-262. (Pubitemid 23222774)
47. Groneberg DA, Eynott PR, Lim S, et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 2002;40(4):367-373. (Pubitemid 34595588)
48. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J. 2002;361(pt 3):537-546. (Pubitemid 34177823)
49. Kirkham S, Kolsum U, Rousseau K, Singh D, Vestbo J, Thornton DJ. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(10):1033-1039.